New York State Common Retirement Fund’s Bright Minds Biosciences DRUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$183K Hold
2,600
﹤0.01% 2408
2026
Q1
$190K Hold
2,600
﹤0.01% 2258
2025
Q4
$203K Hold
2,600
﹤0.01% 2294
2025
Q3
$158K Sell
2,600
-1,500
-37% -$58.2K ﹤0.01% 2404
2025
Q2
$107K Buy
+4,100
New +$123K ﹤0.01% 2550

Other funds holding DRUG

New York State Common Retirement Fund's DRUG Position: Q2 2026 in Review

New York State Common Retirement Fund held its Bright Minds Biosciences (DRUG) position steady in Q2 2026 at 2,600 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

New York State Common Retirement Fund first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. The position peaked at $203K in Q4 2025. 11 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • New York State Common Retirement Fund held 2,600 shares of Bright Minds Biosciences worth $183K as of Q2 2026.
  • New York State Common Retirement Fund left its Bright Minds Biosciences share count unchanged in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2408 holding.
  • New York State Common Retirement Fund first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
  • New York State Common Retirement Fund's Bright Minds Biosciences position peaked at $203K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.